Amryt Pharma

Amryt Pharma, a Pharmaceutical Preparation Manufacturing company headquartered in Ireland, reported total carbon emissions of approximately 368,480 kg CO2e in 2021. This figure is based on inherited emissions data from its parent company, Amryt Pharma plc. The company did not disclose specific Scope 1, Scope 2, or Scope 3 emissions data for 2021, and Scope 3 data for 'purchased goods and services' was missing.

In 2020, Amryt Pharma's total carbon emissions were approximately 441,380 kg CO2e, also inherited from Amryt Pharma plc. Similar to 2021, specific Scope 1, Scope 2, and Scope 3 emissions data were not disclosed for 2020, and Scope 3 data for 'purchased goods and services' was missing.

Amryt Pharma does not have publicly available, specific emissions reduction targets or commitments, nor does it have Science Based Targets initiative (SBTi) targets directly. However, its ultimate parent company, Chiesi Farmaceutici S.p.A., has SBTi targets and is a participant in the RTZ initiative, which may cascade down to Amryt Pharma.